VANCOUVER, BRITISH COLUMBIA--(Marketwire - July 18, 2008) - Neovasc Inc. (TSX VENTURE:NVC), formerly Medical Ventures Corp., a company developing and marketing specialty vascular devices, today announced it has hired GendeLLindheim BioCom Partners, LLC, as its agency of record. The firm, known as BioCom Partners, is a New York City-based public and investor relations firm that specializes in supporting the growth of emerging and established life sciences companies. BioCom Partners will provide counsel to Neovasc on investor relations efforts in the U.S. on an ongoing basis. Principals Stephen Gendel and Barbara Lindheim bring professional expertise in media, financial and investor relations to their clients. BioCom Partners has no beneficial equity interest in Neovasc and will be paid in cash on a monthly basis for the service provided. Management anticipates the fees for investor relations services will not exceed $100,000 per year.
